BACKGROUND: Resurgence of pertussis in the post-vaccination era has been reported in Western countries. A shift of cases from school-age children to adolescents, adults and children under 1 year of age has been described in the last decade, and mortality rates in infants are still sustained. We aimed to review and discuss the possible vaccination strategies which can be adopted in order to improve the pertussis control, by searches of Pubmed, and websites of US and European Centers for Disease Control and Prevention, between 1st January 2002, and 1st March 2013. DISCUSSION: The following vaccination strategies have been retrieved and analysed: the cocooning strategy, the immunization of pregnant women and newborns, vaccination programs for preschool children, adolescents, adults and health-care workers. Cost-effectiveness studies provide some contrasting data, mainly supporting both maternal vaccination and cocooning. Adolescent and/or adult vaccination seems to be cost-effective, however data from observational studies suggest that this vaccination strategy, used alone, leads to a reduced pertussis burden globally, but does not affect the disease incidence in infants. Moreover, substantial logistical and economic difficulties have to be overcome to vaccinate the largest number of individuals. SUMMARY: The simultaneous use of more than one strategy, including cocooning strategy plus vaccination of adolescents and adults, seems to be the most reasonable preventive measure. The development of new highly immunogenic and efficacious pertussis vaccines continues to be a primary objective for the control of pertussis.
BACKGROUND: Resurgence of pertussis in the post-vaccination era has been reported in Western countries. A shift of cases from school-age children to adolescents, adults and children under 1 year of age has been described in the last decade, and mortality rates in infants are still sustained. We aimed to review and discuss the possible vaccination strategies which can be adopted in order to improve the pertussis control, by searches of Pubmed, and websites of US and European Centers for Disease Control and Prevention, between 1st January 2002, and 1st March 2013. DISCUSSION: The following vaccination strategies have been retrieved and analysed: the cocooning strategy, the immunization of pregnant women and newborns, vaccination programs for preschool children, adolescents, adults and health-care workers. Cost-effectiveness studies provide some contrasting data, mainly supporting both maternal vaccination and cocooning. Adolescent and/or adult vaccination seems to be cost-effective, however data from observational studies suggest that this vaccination strategy, used alone, leads to a reduced pertussis burden globally, but does not affect the disease incidence in infants. Moreover, substantial logistical and economic difficulties have to be overcome to vaccinate the largest number of individuals. SUMMARY: The simultaneous use of more than one strategy, including cocooning strategy plus vaccination of adolescents and adults, seems to be the most reasonable preventive measure. The development of new highly immunogenic and efficacious pertussis vaccines continues to be a primary objective for the control of pertussis.
Authors: Yenlik A Zheteyeva; Pedro L Moro; Naomi K Tepper; Sonja A Rasmussen; Faith E Barash; Natalia V Revzina; Dmitry Kissin; Paige W Lewis; Xin Yue; Penina Haber; Jerome I Tokars; Claudia Vellozzi; Karen R Broder Journal: Am J Obstet Gynecol Date: 2012-05-14 Impact factor: 8.661
Authors: Grace M Lee; Trudy V Murphy; Susan Lett; Margaret M Cortese; Katrina Kretsinger; Stephanie Schauer; Tracy A Lieu Journal: Am J Prev Med Date: 2007-03 Impact factor: 5.043
Authors: B A Halperin; A Morris; D Mackinnon-Cameron; J Mutch; J M Langley; S A McNeil; D Macdougall; S A Halperin Journal: Clin Infect Dis Date: 2011-09-26 Impact factor: 9.079
Authors: James D Cherry; Tina Tan; Carl-Heinz Wirsing von König; Kevin D Forsyth; Usa Thisyakorn; David Greenberg; David Johnson; Colin Marchant; Stanley Plotkin Journal: Clin Infect Dis Date: 2012-03-19 Impact factor: 9.079
Authors: Ricardo da Silva Antunes; Mariana Babor; Chelsea Carpenter; Natalie Khalil; Mario Cortese; Alexander J Mentzer; Grégory Seumois; Christopher D Petro; Lisa A Purcell; Pandurangan Vijayanand; Shane Crotty; Bali Pulendran; Bjoern Peters; Alessandro Sette Journal: J Clin Invest Date: 2018-08-06 Impact factor: 14.808
Authors: Deepak B Salunke; Seth W Connelly; Nikunj M Shukla; Alec R Hermanson; Lauren M Fox; Sunil A David Journal: J Med Chem Date: 2013-07-10 Impact factor: 7.446
Authors: Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti Journal: Hum Vaccin Immunother Date: 2014-11-01 Impact factor: 3.452